| Description | HIVEP3 Human Pre-designed siRNA Set A contains three designed siRNAs for HIVEP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components HIVEP3 siRNA-1: 5 nmol (HPLC) HIVEP3 siRNA-2: 5 nmol (HPLC) HIVEP3 siRNA-3: 5 nmol (HPLC) siRNA Negative HIVEP3 Human Pre-designed siRNA Set A contains three designed siRNAs for HIVEP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components HIVEP3 siRNA-1: 5 nmol (HPLC) HIVEP3 siRNA-2: 5 nmol (HPLC) HIVEP3 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | The Leuconostoc GPDH exhibits dual coenzyme specificity, namely NAD and NADP (Olive and Levy, Biochem., 6, 730 730, 1967). When assayed under conditions that are optimal for the particular coenzyme, the ratio of observed catalytic activity is NAD/NADP = 1.8 | Extinction CoeffA280 nm = 1.0 at 1.0 mg/mlGeneral DescriptionProduct is whole polyclonal antiserum from goats immunized with highly purified mouse complement protein. This product is not a purified IgG fraction. Goats are maintained in FDA certified facilities.Physical Characteristics & Extinction CoeffA280 nm = 1.0 at 1.0 mg/mlGeneral DescriptionProduct is whole polyclonal antiserum from goats immunized with highly purified mouse complement protein. This product is not a purified IgG fraction. Goats are maintained in FDA certified facilities.Physical Characteristics & StructureAntibodies present in the antisera are primarily IgG.ApplicationsImmunodiffusion: Effective against NMS and plasma at 1/32 dilution Suggested starting dilutions:Western Blot: 1/500 to 1/1000. Most effective against non-reduced antigen.ELISA: 1/500 to 1/2000... Read More | Purity>97% by SDS-PAGE and HPLC analyses.Additional sequence informationN-terminal Glycine.FunctionChemotactic for monocytes and T-lymphocytes. Binds to CXCR3.Post-translationalCXCL10(1-73) is produced by proteolytic cleavage after secretion from keratinocytes | Inquire |